Anita Venkiteswaran

Healthcare Executive I Angel Investor I Former McKinsey Consultant, PE Investor, Novartis BD&L I Harvard MBA I IIT Engineer.

📍 United States🔄 Updated October 2026💼 2 investments📅 5 years investing🗓 Last invested Jan 2021
VC🌍 United States
2
Total investments
1
Early stage
0
Mid stage
1
Late stage
5y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Member, Investor
2021
HBS Alumni Angels of Greater New York is the largest angel group in NY with 350+ angel investors and growing. Our members have invested $31+ million across 137+ exciting early stage companies. This is an alumni-run presence and is not managed by Harvard Business School (HBS). We meet monthly to hear pitches in person from the best entrepreneurs. On average, we invest in 1-2 companies per month a few weeks after they pitch and our members complete their assessment. Our angel investor members are Harvard Business School and other Harvard University alumni who invest on an individual basis. NO AFFILIATION to Harvard is required to pitch.
Private Investor
2021
What If Ventures began as a passion project to fund Mental Health startups. As the firm scaled to more than $100mm AUM and 4,000 LPs, the investment thesis has broadened to include a number of verticals with a core focus on Health and Freedom. We are a group of 4,000 passionate individuals funding cutting edge solutions to the worlds biggest problems. We fund solutions targeting the most stigmatized healthcare indications and some of the most difficult industrial and commercial problems facing society today. Our syndicate members are angel investors, family offices, healthcare providers, donor advised funds, and individuals who have been impacted personally by the problems we aim to help solve. We invest in startups from Seed to Pre-IPO. We accept investors of all shapes, sizes, walks of life and interests. Please get in touch if you would like to learn more.
Experience · 6 entries
All (6)
Investments (2)
2021
Member, Investor
2021
HBS Alumni Angels of Greater New York is the largest angel group in NY with 350+ angel investors and growing. Our members have invested $31+ million across 137+ exciting early stage companies. This is an alumni-run presence and is not managed by Harvard Business School (HBS). We meet monthly to hear pitches in person from the best entrepreneurs. On average, we invest in 1-2 companies per month a few weeks after they pitch and our members complete their assessment. Our angel investor members are Harvard Business School and other Harvard University alumni who invest on an individual basis. NO AFFILIATION to Harvard is required to pitch.
Private Investor
2021
What If Ventures began as a passion project to fund Mental Health startups. As the firm scaled to more than $100mm AUM and 4,000 LPs, the investment thesis has broadened to include a number of verticals with a core focus on Health and Freedom. We are a group of 4,000 passionate individuals funding cutting edge solutions to the worlds biggest problems. We fund solutions targeting the most stigmatized healthcare indications and some of the most difficult industrial and commercial problems facing society today. Our syndicate members are angel investors, family offices, healthcare providers, donor advised funds, and individuals who have been impacted personally by the problems we aim to help solve. We invest in startups from Seed to Pre-IPO. We accept investors of all shapes, sizes, walks of life and interests. Please get in touch if you would like to learn more.
2019
Principal
Feb 2019
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.
mid stageBiotechnology
2016
Principal
Dec 2016
Focus Financial Partners is a leading partnership of independent, fiduciary wealth management firms. Focus provides access to best practices, resources and continuity planning for its partner firms who serve individuals, families, employers and institutions with comprehensive wealth management services. Focus partner firms benefit from the synergies, scale, economics and best practices offered by Focus to achieve their business objectives.
2012
Associate
Jul 2012
CI Capital Partners LLC is a leading North American private equity investment firm that has invested in middle-market companies since 1993. CI Capital forms partnerships with experienced management teams and entrepreneurs to build substantial businesses through add-on acquisitions, organic growth, and operational improvements. Since inception, CI Capital and its portfolio companies have made over 400 acquisitions representing more than $10 billion in enterprise value. For more information on CI Capital Partners, please visit www.cicapllc.com.
Show all 6 entries ↓